I get the frustration - although I would place it with a much higher weight on Anavex.
We can't have Wild West Snakeoil conditions for approving drugs and other treatments. The regulator obviously need qualified data and information from applicants and once they had from Anavex, the EMA process has had no delays - the ball is currently with Anavex.
Market Data 
Markets 
AI
